Shashi K. Agarwal Center for Contemporary and Complementary Cardiology, 2227 US Highway 1, Suite 309, North Brunswick, NJ 08902, USA

Authors

Shashi K. Agarwal
Center for Contemporary and Complementary Cardiology, 2227 US Highway 1, Suite 309, North Brunswick, NJ 08902, USA

Article Information

*Corresponding Author: Shashi K. Agarwal, Center for Contemporary and Complementary Cardiology, 2227 US Highway 1, Suite 309, North Brunswick, NJ 08902, USA

Received date: April  03, 2021
Accepted date: April 10, 2021
published date: April 14, 2021

Citation: Shashi K. Agarwal. (2021) “Cardiovascular Dangers of Air Pollution.” J Clinical Cardiology Interventions, 2(3); DOI: http;//doi.org/04.2021/1.1013
Copyright: © 2021 Shashi K. Agarwal. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited

Abstract

Cardiovascular diseases are the leading cause of global morbidity and mortality. Besides imparting a tremendous amount of human suffering, they also inflict huge direct and indirect financial costs on the worldwide society. With the ready availability of affordable therapeutics globally and the lack of newer innovations, preventive interventions are gaining increasing importance in the management of cardiovascular diseases. Air pollution is often a modifiable risk factor, and clean air can reduce the global burden of cardiovascular diseases. However, almost nine out of ten people on this earth are exposed to unacceptable levels of toxic air pollution. This paper reviews the effects of air pollution on cardiovascular diseases.


Keywords: cardiovascular diseases; air pollution; PM2.5; PM10; CO; O3; SO2; NO2

Introduction

Air pollution, both ambient and indoor, is a major global health problem [1]. It is responsible for considerable morbidity and disability, and an enormous number of premature deaths annually [2]. According to WHO, almost 91% of the world’s population lives in places where the air is polluted [3]. Cities tend to be densely populated and bear the major brunt of ambient air pollution, as more than half the world’s population resides in cities [4,5].

Common outdoor sources of ambient air pollution are vehicular and airplane traffic, power generation units, industrial facilities, or municipal and agricultural waste sites [6]. Indoor air pollution is primarily related to cooking (burning of oil, wood, coal, and food) and cigarette smoke, while house dust, mold spores, common consumer products such as cleaning materials and electronic appliances, and emissions from building materials also contribute [7-9]. Household air quality can be 2 to 5 times worse than outdoor air quality and people spend almost 90% of their time indoors (home or workplace) [10]. Air quality measurements are typically reported in terms of daily or annual mean concentrations of PM particles per cubic meter of air volume (m3). Routine air quality measurements typically describe such PM concentrations in terms of micrograms per cubic meter (μg/m3). WHO air quality guideline values, according to a document of May 2, 2018, are: 10 μg/m3 annual mean and 25 μg/m3 24-hour mean for fine particulate matter (PM2.5) and 20 μg/m3 annual mean and 50 μg/m3 24-hour mean for coarse particulate matter (PM10) [6].

The air pollutome is a complex mixture of gases and particulate matter (PM)n [11,12]. Gases include carbon monoxide (CO), sulfur dioxide (SO2), nitrogen oxide (NO2), and ozone (O3)1. Particulate matter includes nitrates, sulfates, elemental and organic carbon, organic compounds, several biological compounds, and various metals [12]. Although both gaseous and particulate pollution is harmful to human health [13], PM exposure appears to be more dangerous [14]. PM is commonly classified based on size as coarse (aerodynamic diameter <10 μm; PM10), fine (diameter <2.5 μm; PM2.5), or ultrafine (<0.1 μm; PM0.1) [15]. Coarse particles often appear as dust or haze and may affect the upper airways and cause mucosal irritation and cough. Finer particles are invisible and more toxic. While fine particles reach the lung alveoli, ultrafine particles easily cross the alveolar-capillary membrane and enter the bloodstream, causing not only vascular inflammation and endothelial dysfunction, but also deleteriously affecting virtually all cells in the body [15].

The Global Burden of Disease (GBD) study has recognized air pollution (both ambient and household) as a major risk factor for, morbidity, disability-adjusted life-years, and premature mortality [16-18]. Ambient and household air pollution affect nine out of ten people, globally [19]. Air pollution leads to several non-communicable diseases including cardiovascular diseases (CVD), respiratory diseases, neurodevelopmental disorders, birth defects, skin ailments, and many kinds of cancers [20]. Cohen and group estimate that air pollution is responsible for over 100 million years of life lost, adjusted to the number of years lived with disability [21] WHO reports that the combined effects of ambient (outdoor) and household air pollution results in almost seven million premature deaths every year [22] According to the Lancet Commission on pollution and health, these represent three times more premature deaths than AIDS, tuberculosis, and malaria combined [23]. Air pollution has also caused 15 times more deaths than all wars and other violent causes combined [23]. A recent GBD report ranked ambient air pollution eighth in a list of 79 mortality risk factors [24]. Air pollution-related health burden leads to a significant direct and indirect cost for the community [25].

Air pollution is an important preventable and modifiable risk factor of cardiovascular disease [26].

Discussion

CVDs are a major cause of non-communicable diseases in the world [27]. They are also the number one killer globally, being responsible for at least 19 million of the 56 million annual deaths worldwide [18,28].

Air pollution causes harm to multiple bodily organs with the cardiovascular system often the main target of its harmful effects [29,30]. Air pollution also increases cardiovascular mortality [30-32]. The Women's Health Initiative Observational Study found that every 10 μg/cm3 increase in PM2.5 was associated with a 76% increase in fatal cardiovascular events [31]. The Nurses' Health Study found that every 10 μg/cm3 increase in PM10 was associated with a 43% increase in fatal coronary heart disease [32]. The Global Burden of Diseases study estimated that in 2015, air pollution accounted for 19% of all cardiovascular death, 21% of deaths due to stroke, and 24% deaths due to ischemic heart disease [30].

Pollution exposure not only deleteriously affects the lipids, but also increases vascular oxidative stress, endothelium dysfunction, atherosclerosis, and thrombo-inflammation [33-36]. It is also associated with autonomic imbalance, disturbed cardiovascular hemodynamics, and electrical instability [37-39].

CVDs include coronary artery/heart disease (CAD/CHD) high blood pressure (HTN), stroke, heart failure (HF), cardiac arrhythmias (including sudden cardiac death (SCD)), congenital heart disease (CoHD), peripheral arterial disease (PAD), vasculogenic erectile dysfunction (ED) and venous thromboembolism (VTE) [29].

Pollution and HTN

HTN is a major public health problem worldwide [40]. It is responsible for an enormous cardiovascular disease burden and was associated with 10.4 million deaths in 2017 [41-42].

Several studies from all over the world have shown that air pollution significantly increases the incidence of hypertension [43]. A study from China found an association of both gaseous and particulate air pollutants to be associated with hypertension in men [44]. A study from Canada reported that an increase of 10 μg/m3 of PM2.5 significantly increased the incidence of hypertension in Ontario [45]. A study from Switzerland demonstrated that even short-term exposure to low levels of air pollution (PM10) was associated with a significant increase of systolic and pulse pressure [46]. Studies implicate indoor air pollution and exposure to road traffic pollution as major risk factors for the development of hypertension [47,48]. Exposure to PM has also been shown to increase the risk of gestational hypertension and pre-eclampsia [49].

Pollution and Coronary Disease

CAD/CHD is an atherosclerotic process progressing to plaque formation in the coronary arteries [50]. This can cause a non-fatal or fatal myocardial infarction, even if the lesion is non-stenotic [51].

Several observational studies indicate an association between PM exposure and subclinical atherosclerosis [52]. Studies have documented the enhancing effects of air pollution on the development of high-risk coronary plaques, coronary artery calcification, and myocardial infarction [53-55]. An increase in myocardial infarction has been seen after both short-term and long-term exposure [56.57]. An association with CHD mortality has also been noted with PM2.5 exposure [58,59].

Pollution and Stroke

Stroke is a leading cause of long-term disability and the second leading cause of death in the world [60]. The lifetime risk of stroke is on the increase [61].

The strong association between air pollution and the increased incidence of stroke is well established [62]. Both short-term and long-term exposure to air pollution increases stroke [63,64]. A meta-analysis of 94 studies, found that short-term exposures to PM2.5 (per 10 µg/m3 increase during the prior few hours-to-days) increased the risk for stroke by 10% [65]. A recent prospective cohort study from China (117,575 individuals) found that residential exposure to PM2.5 over the long term increased the risk of incident stroke by 13%, ischemic stroke by 20%, and hemorrhagic stroke by 12%, for each increase of 10 μg/m3 [66]. Air pollution exposure also leads to an increased risk of stroke-related hospital admission and mortality [67].

Pollution and Heart Failure

Heart failure (HF) affects 26 million people globally and is responsible for considerable suffering [68,69]. These patients are prone to recurrent hospitalizations and have poor survival [70,71]. Its prevalence is on the rise [72]. HF has an estimated annual cost of $108 billion, globally [73].

Several meta-analytic studies have linked PM2.5 exposure with heart failure [74]. In humans, short-term air pollution exposure, to carbon monoxide, sulfur dioxide, nitrogen dioxide, or particulate matter <2.5 μm is associated with increased HF hospitalization and mortality [74,75].. Ward-Caness and group estimated that an increase of 1 μg/m3 in annual average PM2.5 at the patient's residence is associated with a 13% higher mortality risk in heart failure patients [76]. Shah et al estimated that almost 8000 heart failure-related hospitalizations in the USA can be prevented by reducing median daily PM2·5 concentrations by a mean of 3·9 μg/m3 [74].

Pollution and Arrhythmias

Cardiac arrhythmia is defined as any change from the normal sequence of electrical impulses [77]. Arrhythmia is a common cardiovascular event and is associated with increased cardiovascular health risks, such as heart failure and stroke, resulting in reduced quality of life, increased disability, high rate of premature mortality, and increased medical care costs [78,79].

Air pollution has been implicated in the pathogenesis of heart rhythm disturbances, both of supraventricular and ventricular origin [80,81]. Several gases, including NO2, O3, and CO have all been shown to be hazardous to the cardiac rhythm [82,83]. Particulate matter, especially PM2.5 has also been linked to an increased risk of arrhythmias and appears to have a stronger deleterious effect than gaseous pollution [84,85]. In a meta-analysis of 23 studies. Song et al found that short-term exposures to PM2.5 (10 µg/m3 or more increase during the prior few hours-to-days) significantly increased the risk for arrhythmia [86]. Ventricular pro-arrhythmic activity related to air pollution has been described, in healthy participants. older participants, heavy alcohol drinkers, diabetics, those with BMI >25, and the physically inactive [86-89]. About 15% of all deaths and 50% of deaths due to CVD are caused by sudden cardiac death (SCD), and approximately 80% of these SCDs are due to ventricular arrhythmias [90]. In a study conducted on >5000 individuals in Rome, both PM and CO on the day of exposure predicted SCD [91]. A study conducted in Sao Paulo also reported that ventricular tachycardia and fibrillation were also positively associated with increases in CO, NO2, and PM10 in the ambient air [92]. Other studies have noted similar associations, including in patients with implantable cardioverter-defibrillators [93-95].  Both particulate and gaseous components in the air pollutome are associated with increased cardiac arrest and cardiac mortality [96].

Pollution and Valvular Diseases

Valvular heart disease may be due to congenital, rheumatic, or degenerative heart diseases [97]. Valvular diseases often lead to the development of cardiac arrhythmias and heart failure [98]. They are associated with high rates of disability and increased mortality [99].

Excessive exposure to PM2.5 appears to result in an increased progression of mitral annular calcification [100]. Road traffic-related air pollution is harmful for ventricular function and is therefore associated with an increased prevalence of tricuspid and mitral regurgitation [101].

Congenital Heart Disease

Congenital heart defects are common and may lead to intra-uterine or immediate post-birth death [102,103]. Because of advances in care and treatment, most of the live births with CoHD now survive into adulthood [104].

Ritz and associates found a relationship between exposure to CO with ventricular septal defects and exposure to O3 with valvular, aortic, and truncal defects [105]. 

Heart Transplant

Heart transplantation not only improves the quality of life but provides additional 10.7 years of survival to terminal HF patients [106].

Air pollution can have a detrimental effect on these patients also. In a study by Al-Kindi et al, annual exposure to PM2.5 per 10ug/m3 increment increased mortality by an average of 26% in heart transplant patients [107].

Pollution and PAD

PAD, diagnosed by an ABI <90, is an indication of systemic atherosclerosis and is associated with a 2-fold increased risk (over 10 years) of all-cause mortality, cardiovascular mortality, and major coronary event rate. It also results in a significant functional decline [108-110].

Air pollution exposure, including that from road traffic, is strongly associated with atherosclerosis [111]. Ward-Caviness and group noted that individuals living closer to road traffic exhibited a higher risk of PAD [112]. Hoffmann et al determined that the safe distance for significantly avoiding exposure to road traffic-related air pollution may be 200 meters away from a major road [113]. They found that living within 50 meters of a major road increased the risk of PAD by 77% when compared to those living 200 meters away [113].

Pollution and Erectile Dysfunction

Erectile dysfunction (ED), defined as the inability of a man to achieve or maintain an erection [114]. It is a common disorder in men, often associated with conditions such as diabetes mellitus and other cardiovascular diseases [115,116]. ED often leads to depression and reduced quality of life [117,118].

ED shares several common risk factors implicated in other cardiovascular diseases, including air pollution [119]. Exposure to PM2.5 is associated with increased oxidative stress, vascular inflammation, endothelial dysfunction, and atherosclerosis [120,121]. Endothelial dysfunction and atherosclerosis are both strongly associated with ED [122]. Tallon et al, found in their research that exposure to PM2.5 was consistently associated with higher odds of developing ED [123]. Gasoline vehicular exhaust exposure has also been deleteriously linked with ED [124].

Pollution and Venous Disease

Venous thromboembolism (VTE) comprises deep-vein thrombosis (DVT) and pulmonary embolism (PE) [125-127]. DVT, besides being associated with PE, may result in post-thrombotic syndrome which is associated with significant health impairment and leads to frequent long-term major disability [128]. PE is an extremely dangerous condition with a high fatality rate [129].

Several animal studies show that air pollution is associated with an increase in thrombus formation [130]. Air pollution is associated with higher blood viscosity, elevated homocysteine levels, increased platelet aggregation, increased coagulation activity, and decreased prothrombin time [131-135]. However, the association between air pollution and VTE remains somewhat inconsistent [136,137].  A systematic review of 11 studies found a positive association between air pollution and VTE risk [136], while another meta-analysis involving several studies involving 700.000 events found no significant association [137].

Pollution and CVD risk factors

Pollution is also associated with many other CVD risk factors, such as diabetes mellitus, dyslipidemia, metabolic syndrome, obstructive sleep apnea, and atherosclerosis [138-143].

Conclusion

Air pollution is a major health concern all over the world. Common sources are industrial facilities, heat and power generation units, industrial and agricultural waste sites, vehicular and airplane traffic, cigarette smoke, and residential use of polluting fuels. These emit several environmental air pollutants including carbon monoxide, nitrogen dioxide, sulfur dioxide, ozone, and particulate matter. Particulate matter is made up of nitrates, sulfates, and organic carbon, organic compounds, endotoxin, cell fragments, and a variety of metals. Particulate matter is broadly defined as coarse (PM10:<10 μm) or fine (PM2.5:<2.5 μm) according to their aerodynamic diameter. Both acute and chronic exposure to these, especially PM2.5 or smaller particles, increases the risk of cardiovascular morbidity and mortality. Air pollution is a potentially modifiable cardiovascular risk factor.

Acknowledgements: None

Funding: None

Conflict of Interest: None

References

  1. World Health Assembly. Health and the environment: draft road map for an enhanced global response to the adverse health effects of air pollution: report by the Secretariat. World Health Organization.
  2. GBD 2017 Risk Factor Collaborators. (2018). Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2016:392(10159):1923–1994.
  3. https://www.who.int/airpollution/ambient/en/ - accessed April 3, 2021.
  4. Anenberg SC, Achakulwisut P, Brauer M, Moran D, Apte JS, Henze DK. (2019). Particulate matter-attributable mortality and relationships with carbon dioxide in 250 urban areas worldwide. Sci Rep9(1):11552.
  5. United Nations.2019. World Urbanization Prospects: the 2018 Revision. ST/ESA/SER.A/420. New York, NY: United Nations, Department of Economic and Social Affairs, Population Division.
  6. https://www.who.int/en/news-room/fact-sheets/detail/ambient-(outdoor)-air-quality-and-health – accessed April 3, 2021.
  7. Wallace L. (1996). Indoor particles: A review. J. Air Waste Manag. Assoc. 46:98–126.
  8. Ferro A.R., Kopperud R.J., Hildemann L.M. (2004). Elevated personal exposure to particulate matter from human activities in a residence. J. Expo. Sci. Environ. Epid. 14:S34–S40.
  9. Kumar P., Imam B. (2013). Footprints of air pollution and changing environment on the sustainability of built infrastructure. Sci. Total Environ. 444:85–101.
  10. Leech J.A., Nelson W.C., Burnett R.T., Aaron S., Raizenne A.M.E. (2002). It’s about time: A comparison of canadian and american time–activity patterns. J. Expo. Sci. Environ. Epidemiol. 12:427–432.
  11. Bai L, Wang J, Ma X, Lu H. (2018). Air Pollution Forecasts: An Overview. Int J Environ Res Public Health. 15(4):780. Published 2018 Apr 17.
  12. Sompornrattanaphan M, Thongngarm T, Ratanawatkul P, Wongsa C, Swigris JJ. (2020). The contribution of particulate matter to respiratory allergy. Asian Pac J Allergy Immunol. 38(1):19-28.
  13. World Health Organization. Ambient (outdoor) air quality and health. Geneva, Switzerland: World Health Organization; 2018.
  14. Miller MR, Shaw CA, Langrish JP. (2012). From particles to patients: oxidative stress and the cardiovascular effects of air pollution. Future Cardiol. 8(4):577–602.
  15. Burnett R, Chen H, Szyszkowicz M, et al. (2018). Global estimates of mortality associated with long-term exposure to outdoor fine particulate matter. Proc Natl Acad Sci U S A. 115(38):9592–9597.
  16. Lim SS, Vos T, Flaxman AD. (2012). A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 380:2224–2260.
  17. OECD Health at a glance 2017: OECD Indicators. Published on November 10 2017. Available at: http://www.oecd.org/health/health-at-a-glance-19991312.htm.
  18. GBD 2017 DALYs and HALE Collaborators Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1859–1922.
  19. WHO - World Health Organization-Ambient Air Pollution: A global assessment of exposure and burden of disease. Available online at: https://www.who.int/phe/publications/air-pollution-global-assessment/en/ Accessed 20 April 2019.; WHO Ambient and household air pollution and health. Available online at: http://who.int/phe/health_topics/out-doorair/databases/en/ Accessed 20 April 2019.
  20. Franchini M, Mannucci PM, Harari S, Pontoni F, Croci E. (2015). The health and economic burden of air pollution. Am J Med. 128(9):931–932.;
  21. Franchini M, Mannucci PM. (2011).Thrombogenicity and cardiovascular effects of ambient air pollution. Blood. 118(9): 2405–2412.
  22. Cohen AJ, Brauer M, Burnett R, et al. (2017). Estimates and 25-year trends of the global burden of disease attributable to ambient air pollution: an analysis of data from the Global Burden of Diseases Study 2015. Lancet. 389(10082):1907–1918.
  23. https://www.who.int/health-topics/air-pollution#tab=tab_1 – accessed April 3, 2021.
  24. Philip J Landrigan, Richard Fuller, Nereus J R Acosta, et al. The Lancet Commission on pollution and health. The Lancet, Volume 391, Issue 10119, 2018,Pages 462-512.
  25. GBD 2017 Risk Factor Collaborators Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1923–1994.
  26. WHO - World Health Organization-Ambient Air Pollution: A global assessment of exposure and burden of disease.
  27. R.D. Brook, S. Rajagopalan, C.A. Pope 3rd, J.R. Brook, A. Bhatnagar, A.V. Diez-Roux, et al. (2010). Particulate matter air pollution and cardiovascular disease: An update to the scientific statement from the American Heart Association. Circulation, 121 (21), pp. 2331-2378.
  28. GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all‐cause mortality, and cause‐specific mortality for 249 causes of death, 1980‐2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016; 388: 1459–544.
  29. Loxham M, Davies DE, Holgate ST. (2019). The health effects of fine particulate air pollution. BMJ. 367:l6609.
  30. Ahmed Tawakol et al, (2021). A leucopoietic-arterial axis underlying the link between ambient air pollution and cardiovascular disease in humans, European Heart Journal; ehaa982.
  31. Miller KA, Siscovick DS, Sheppard L, Shepherd K, et al. (2007). Long-term exposure to air pollution and incidence of cardiovascular events in women. N Engl J Med. 356:447–58.
  32. Puett RC, Schwartz J, Hart JE, Yanosky JD, Speizer FE, Suh H, et al. (2008). Chronic particulate exposure, mortality, and coronary heart disease in the nurses' health study. Am J Epidemiol. 168:1161–8.
  33. Li R, Navab M, Pakbin P, et al. (2013). Ambient ultrafine particles alter lipid metabolism and HDL anti-oxidant capacity in LDLR-null mice. J Lipid Res. 54:1608–1615.
  34. Liang S, Zhang J, Ning R, Du Z, Liu J, Batibawa JW, Duan J, Sun Z. (2020). The critical role of endothelial function in fine particulate matter-induced atherosclerosis. Part Fibre Toxicol. 17(1):61.
  35. Araujo JA. (2010). Particulate air pollution, systemic oxidative stress, inflammation, and atherosclerosis. Air Qual Atmos Health. 4:79–93’
  36. Robertson S, Miller MR. (2018). Ambient air pollution and thrombosis. Part Fibre Toxicol. 15(1):1.
  37. Künzli N, Jerrett M, Garcia-Esteban R, Basagaña X, Beckermann B, Gilliland F, Medina M, Peters J, Hodis HN, Mack WJ. (2010). Ambient air pollution and the progression of atherosclerosis in adults. PLoS One. 5(2):e9096.
  38. Pope C.A., 3rd, Verrier R.L., Lovett E.G., Larson A.C., Raizenne M.E., Kanner R.E., Schwartz J., Villegas G.M., Gold D.R., Dockery D.W. (1999). Heart rate variability associated with particulate air pollution. Am. Heart J. 138:890–899.
  39. R.D. Brook, S. Rajagopalan, C.A. Pope 3rd, et al. (2010). Particulate matter air pollution and cardiovascular disease: an update to the scientific statement from the American Heart Association Circulation, 121, pp. 2331-2378.
  40. Cakmak S, Dales R, Kauri LM, Mahmud M, Van Ryswyk K, Vanos J, et al. (2014). Metal composition of fine particulate air pollution and acute changes in cardiorespiratory physiology. Environ Pollut. 189:208–14.
  41. Zhou B., Danaei G., A Stevens G., et al. (2019). Long-term and recent trends in hypertension awareness, treatment, and control in 12 high-income countries: An analysis of 123 nationally representative surveys. Lancet. 394:639–651.
  42. Yusuf S., Joseph P., Rangarajan S., et al. (2020). Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): A prospective cohort study. Lancet. 395:795–808.
  43. Collaborators GBDRF Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1923–1994.
  44. Cai Y, Zhang B, Ke W, et al. (2016). Associations of short-term and long-term exposure to ambient air pollutants with hypertension: a systematic review and meta-analysis. Hypertension. 68:62–70.
  45. Dong GH, Qian ZM, Xaverius PK, Trevathan E, Maalouf S, Parker J, et al. (2013). Association between long-term air pollution and increased blood pressure and hypertension in China. Hypertension,  61:578–584.
  46. Chen H, Burnett RT, Kwong JC, Villeneuve PJ, Goldberg MS, Brook RD, et al. (2014). Spatial association between ambient fine particulate matter and incident hypertension. Circulation; 129:562–569.
  47. Tsai DH, Guessous I, Riediker M, Paccaud F, Gaspoz JM, Theler JM, et al. (2015). Short-term effects of particulate matters on pulse pressure in two general population studies. J Hypertens; 33:1144–1152.
  48. Li L, Yang A, He X, Liu J, Ma Y, Niu J, Luo B. (2020). Indoor air pollution from solid fuels and hypertension: A systematic review and meta-analysis. Environ Pollut. 259:113914.
  49. Yaxian Pang, Shipeng Liu, Lina Yan, et al. Associations of long-term exposure to traffic-related air pollution with risk of valvular heart disease based on a cross-sectional study. Ecotoxicology and Environmental Safety.Volume 209, 2021, 111753.
  50. Pedersen M, Stayner L, Slama R, Sorensen M, Figueras F, Nieuwenhuijsen MJ, et al. . (2014). Ambient air pollution and pregnancy-induced hypertensive disorders: a systematic review and meta-analysis. Hypertension  64:494–500.
  51. Libby P. (2013). Mechanisms of acute coronary syndromes and their implications for therapy. The New England Journal of Medicine. 368(21):2004–2013.
  52. Maddox TM, Stanislawski MA, Grunwald GK, et al. (2014). Nonobstructive coronary artery disease and risk of myocardial in-farction. JAMA. 312:1754–1763.
  53. Jilani MH, Simon-Friedt B, Yahya T, et al. (2020). Associations between particulate matter air pollution, presence and progression of subclinical coronary and carotid atherosclerosis: A systematic review. Atherosclerosis. 306:22-32.
  54. Yang S, Lee SP, Park JB, Lee H, Kang SH, Lee SE, Kim JB, Choi SY, Kim YJ, Chang HJ. (2019). PM2.5 concentration in the ambient air is a risk factor for the development of high-risk coronary plaques. Eur Heart J Cardiovasc Imaging. 20(12):1355-1364.
  55. Huynh Q, Marwick TH, Venkataraman P, Knibbs LD, Johnston FH, Negishi K. (2020). Long-term exposure to ambient air pollution is associated with coronary artery calcification among asymptomatic adults. Eur Heart J Cardiovasc Imaging. jeaa073.
  56. Madrigano J, Kloog I, Goldberg R, Coull BA, Mittleman MA, Schwartz J. (2013). Long-term exposure to PM2.5 and incidence of acute myocardial infarction. Environ Health Perspect. 121:192–6.
  57. Wu, Y., Li, M., Tian, Y. et al. (2019). Short-term effects of ambient fine particulate air pollution on inpatient visits for myocardial infarction in Beijing, China. Environ Sci Pollut Res 26, 14178–14183.
  58. Cesaroni G, Forastiere F, Stafoggia M, Andersen ZJ, Badaloni C, Beelen R, et al. (2014). Long term exposure to ambient air pollution and incidence of acute coronary events: prospective cohort study and meta-analysis in 11 European cohorts from the ESCAPE Project. BMJ.
  59. Yuewei Liu, Jingju Pan, Chuangang Fan, et al. (2021). Short-Term Exposure to Ambient Air Pollution and Mortality From Myocardial Infarction. J Am Coll Cardiol, 77 (3) 271–281.
  60. Pope CA, III, Burnett RT, Thurston GD, Thun MJ, Calle EE, Krewski D, et al. (2004). Cardiovascular mortality and long-term exposure to particulate air pollution: epidemiological evidence of general pathophysiological pathways of disease. Circulation  109:71–7.
  61. Group GBDNDC. Global, regional, and national burden of neurological disorders during 1990-2015: A systematic analysis for the global burden of disease study 2015. Lancet Neurol. 2017;16:877-897.
  62. GBD 2016 Lifetime Risk of Stroke Collaborators, et al. Global, Regional, and Country-Specific Lifetime Risks of Stroke, 1990 and 2016. N Engl J Med. 2018;379(25):2429–2437.
  63. Wang Y, Eliot MN, Wellenius GA. (2014). Short-term changes in ambient particulate matter and risk of stroke: a systematic review and meta-analysis. J Am Heart Assoc. 3(4): e000983.
  64. Mustafic H, Jabre P, Caussin C, Murad MH, Escolano S, Tafflet M, et al. (2012). Main air pollutants and myocardial infarction: a systematic review and meta-analysis. JAMA,  307:713–21.
  65. Amini H, Dehlendorff C, Lim YH, et al. (2020). Long-term exposure to air pollution and stroke incidence: A Danish Nurse cohort study. Environ Int. 142:105891.
  66. Shah AS, Lee KK, McAllister DA, Hunter A, Nair H, Whiteley W, Langrish JP, Newby DE, Mills NL. Short term exposure to air pollution and stroke: systematic review and meta-analysis. BMJ 2015; 350:h1295.
  67. Huang K., Liang F., Yang X., Liu F., Li J., Xiao Q., Chen J., Liu X., Cao J., Shen C., et al. (2019). Long term exposure to ambient fine particulate matter and incidence of stroke: Prospective cohort study from the China-PAR project. BMJ. 367:l6720.
  68. Niu Z, Liu F, Yu H, Wu S, Xiang H. (2021).  Association between exposure to ambient air pollution and hospital admission, incidence, and mortality of stroke: an updated systematic review and meta-analysis of more than 23 million participants. Environ Health Prev Med. 26(1):15.
  69. Savarese G, Lund LH. (2017). Global public health burden of heart failure. Card Fail Rev  3: 7–11.
  70. Ziaeian B, Fonarow GC. (2016). Epidemiology and aetiology of heart failure. Nat Rev Cardiol  13: 368–378.
  71. Dharmarajan K, Rich MW. (2017). Epidemiology, Pathophysiology, and Prognosis of Heart Failure in Older Adults. Heart Fail Clin. 13(3):417–426.
  72. Ko DT, Alter DA, Austin PC, et al. (2008). Life expectancy after an index hospitalization for patients with heart failure: a population‐based study. Am Heart J. 155:324–331.
  73. Heidenreich PA, Albert NM, Allen LA, et al.; (2013). on behalf of the American Heart Association Advocacy Coordinating Committee; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular Radiology and Intervention; Council on Clinical Cardiology; Council on Epidemiology and Prevention; Stroke Council. Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association.Circ Heart Fail. 6:606–619.
  74. Cook C, Cole G, Asaria P, Jabbour R, Francis DP. (2014). The annual global economic burden of heart failure. Int J Cardiol, 171: 368–376.
  75. Shah AS, Langrish JP, Nair H, et al. Global association of air pollution and heart failure: a systematic review and meta-analysis. Lancet (2013) 382:1039–48.
  76. F. Dominici, R.D. Peng, M.L. Bell, et al. (2006). Fine particulate air pollution and hospital admission for cardiovascular and respiratory diseases. JAMA, 295, pp. 1127-1134.
  77. Ward-Caviness CK, Weaver AM, Buranosky M, et al. (2020). Associations Between Long-Term Fine Particulate Matter Exposure and Mortality in Heart Failure Patients. J Am Heart Assoc. 9(6):e012517.
  78. https://www.heart.org/en/health-topics/arrhythmia - accessed February 21, 2021.
  79. Murakoshi N, Aonuma K. (2013). Epidemiology of arrhythmias and sudden cardiac death in Asia. Circ J. 77(10):2419–2431.
  80. Brugada J, Katritsis DG, Arbelo E, et al. (2020).  2019 ESC guidelines for the management of patients with supraventricular tachycardia. The task force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC): developed in collaboration with the Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J. 41:655–720.
  81. A. Watkins, M. Danilewitz, M. Kusha, et al. (2013). Air pollution and arrhythmic risk: the smog is yet to clear. Can. J. Cardiol., 29 (6), pp. 734-741l.
  82. Berger A., Zareba W., Schneider A. (2006). Runs of ventricular and supraventricular tachycardia triggered by air pollution in patients with coronary heart disease. J Occup Environ Med. 48:1149–1158.
  83. Sarnat S.E., Suh H.H., Coull B.A. (2006). Ambient particulate air pollution and cardiac arrhythmia in a panel of older adults in Steubenville, Ohio. J Occup Environ Med. 63:700–706.
  84. Santos U.P., Terra-Filho M., Lin C.A. (2008). Cardiac arrhythmia emergency room visits and environmental air pollution in Sao Paulo, Brazil. J Epidemiol Community Health. 62:267–272.
  85. Sarnat S.E., Suh H.H., Coull B.A. (2006). Ambient particulate air pollution and cardiac arrhythmia in a panel of older adults in Steubenville, Ohio. J Occup Environ Med. 63:700–706.
  86. Liao D, Shaffer ML, He F, et al. (2011). Fine particulate air pollution is associated with higher vulnerability to atrial fibrillation--the APACR study. J Toxicol Environ Health A. 74(11):693-705.
  87. Song X, Liu Y, Hu Y, Zhao X, Tian J, Ding G, Wang S. (2016). Short-term exposure to air pollution and cardiac arrhythmia: a meta-analysis and systematic review. Int J Environ Res Public Health, 13:642.
  88. He F Shaffer ML Rodriguez-Colon S et al. (2011). Acute effects of fine particulate air pollution on cardiac arrhythmia: the APACR study. Environ Health Perspect. 119: 927-932.
  89. Zhang Z, Kang J, Hong YS, et al. (2020). Long-Term Particulate Matter Exposure and Incidence of Arrhythmias: A Cohort Study. J Am Heart Assoc. 9(22):e016885.
  90. Dahlquist M, Frykman V, Kemp-Gudmunsdottir K, Svennberg E, Wellenius GA, L S Ljungman P. (2020). Short-term associations between ambient air pollution and acute atrial fibrillation episodes. Environ Int. 141:105765.
  91. Mehra R. (2007). Global public health problem of sudden cardiac death. J. Electrocardiol. 40:118–122.
  92. Forastiere F., Stafoggia M., Picciotto S. (2005). A case-crossover analysis of out-of-hospital coronary deaths and air pollution in Rome, Italy. Am J Respir Crit Care Med. 172:1549–1555.
  93. Santos U.P., Terra-Filho M., Lin C.A. (2008). Cardiac arrhythmia emergency room visits and environmental air pollution in Sao Paulo, Brazil. J Epidemiol Community Health. 62:267–272.
  94. Rich D.Q., Schwartz J., Mittleman M.A. (2005). Association of short-term ambient air pollution concentrations and ventricular arrhythmias. Am J Epidemiol. 161:1123–1132.
  95. Rich DQ, Kim MH, Turner JR, et al. (2006). Association of ventricular arrhythmias detected by implantable cardioverter defibrillator and ambient air pollutants in the St Louis, Missouri metropolitan area. Occup Environ Med. 63:591–596.
  96. Folino F, Buja G, Zanotto G,  et al. (2017). Association between air pollution and ventricular arrhythmias in high-risk patients (ARIA study): a multicentre longitudinal study. Lancet Planet Health, 1:e58–64.
  97. Ensor KB Raun LH Persse D. (2013). A case-crossover analysis of out-of-hospital cardiac arrest and air pollution. Circulation. 127: 1192-1199.
  98. Iung B, Vahanian A. (2011). Epidemiology of valvular heart disease in the adult. Nat Rev Cardiol. 8(3):162-72.
  99. Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M. et al. (2013). Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 380(9859):2163–2196.
  100. S. Yadgir, C.O. Johnson, V. Aboyans, et al. (2020). Global, regional, and national burden of calcific aortic valve and degenerative mitral valve diseases, 1990-2017. Circulation, 141, pp. 1670-1680.
  101. Tibuakuu M, Jones MR, Navas-Acien A, et al. (2017). Exposure to ambient air pollution and calcification of the mitral annulus and aortic valve: the multi-ethnic study of atherosclerosis (MESA). Environ Health. 16(1):133. Published 2017 Dec 21.
  102. Pang Y, Liu S, Yan L, et al. (2021). Associations of long-term exposure to traffic-related air pollution with risk of valvular heart disease based on a cross-sectional study. Ecotoxicol Environ Saf. 209:111753.
  103. Ailes EC, Gilboa SM, Riehle-Colarusso T, Johnson CY, et al. (2014). Prenatal diagnosis of nonsyndromic congenital heart defects. Prenat Diagn. 34(3):214-22.
  104. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, et al. (2013). American Heart Association Statistics Committee and Stroke Statistics Subcommittee Heart disease and stroke statistics-2013 update: a report from the American Heart Association. Circulation. 127(1):e6–e245.
  105. Dolk H, Loane M, Garne E, et al. (2011). Congenital heart defects in Europe: prevalence and perinatal mortality, 2000 to 2005. Circulation 123(8): 841–849.
  106. Ritz B., Yu F., Fruin S. (2002). Ambient air pollution and risk of birth defects in Southern California. Am J Epidemiol. 155:17–25.
  107. Lundh L.H., Khush K.K., Cherikh W.S., et al. (2017). The registry of the international society for heart and lung transplantation: Fourty-fourth adult heart transplantation report—2017; Focus theme: Allograft ischemic time. J. Heart Lung Transpl. 36:1037–1046.
  108. Al-Kindi SG, Sarode A, Zullo M, Brook J, Burnett R, Oliveira GH, Huang W, Brook R, Rajagopalan S. (2019). Ambient Air Pollution and Mortality After Cardiac Transplantation. J Am Coll Cardiol. 74(24):3026-3035.
  109. Gerhard-Herman MD, Gornik HL, Barrett C, Barshes NR et al. (2017).  2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 69(11):1465-1508.
  110. Aboyans V, Ricco JB, Bartelink MEL, et al. (2018).  Desormais I. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS) Eur Heart J. 39:763–816.
  111. Fowkes FG, Murray GD, Butcher I, et al. (2008). Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA. 300(2):197–208.
  112. Wang M, Sampson PD, Sheppard LE, Stein JH, Vedal S, Kaufman JD. (2019). Long-Term Exposure to Ambient Ozone and Progression of Subclinical Arterial Disease: The Multi-Ethnic Study of Atherosclerosis and Air Pollution. Environ Health Perspect. 127(5):57001.
  113. C.K. Ward-Caviness, W.E. Kraus, C. Blach, et al. (2018). Associations between residential proximity to traffic and vascular disease in a cardiac catheterization cohort. Arterioscler. Thromb. Vasc. Biol., 38, pp. 275-282.
  114. Hoffmann B, Moebus S, Kröger K, Stang A, Möhlenkamp S, Dragano N, Schmermund A, Memmesheimer M, Erbel R, Jöckel KH. (2009). Residential exposure to urban air pollution, ankle-brachial index, and peripheral arterial disease. Epidemiology. 20(2):280-8.
  115. National Institutes of Health: NIH Consensus Conference Impotence. NIH consensus development panel on impotence. JAMA. 1993;270(1):83–90.
  116. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. (1994). Impotence and its medical and psychosocial correlates: results of the Massachusetts male aging study. J Urol. 151(1):54–61.
  117. Hockenberry MS, Masson P. (2015). Erectile dysfunction in the elderly. Curr Geriatr Rep. 4(1):33–43.
  118. Liu Q, Zhang Y, Wang J, Li S, Cheng Y, Guo J, Tang Y, Zeng H, Zhu Z. (2018). Erectile Dysfunction and Depression: A Systematic Review and Meta-Analysis. J Sex Med. 15(8):1073-1082.
  119. Elterman DS, Bhattacharyya SK, Mafilios M, Woodward E, Nitschelm K, Burnett AL. (2021). The Quality of Life and Economic Burden of Erectile Dysfunction. Res Rep Urol. 13:79-86. Published 2021 Feb 18.
  120. Brook RD, Franklin B, Cascio W, et al. (2004). Expert panel on population and prevention science of the american heart association: Air pollution and cardiovascular disease: a statement for healthcare professionals from the expert panel on population and prevention science of the american heart association. Circulation. 109(21):2655–2671.
  121. Bind MA, Baccarelli A, Zanobetti A, Tarantini L, Suh H, Vokonas P, Schwartz J. (2012). Air pollution and markers of coagulation, inflammation, and endothelial function: associations and epigene-environment interactions in an elderly cohort. Epidemiology. 23(2):332–340.
  122. Kaufman JD, Adar SD, Barr RG, et al. (2016). Association between air pollution and coronary artery calcification within six metropolitan areas in the USA (the Multi-Ethnic Study of Atherosclerosis and Air Pollution): a longitudinal cohort study. The Lancet. 388(10045):696–704.
  123. Kloner RA, Speakman M. (2002). Erectile dysfunction and atherosclerosis. Curr Atheroscler Rep. 4(5):397–401.
  124. Tallon LA, Manjourides J, Pun VC, Mittleman MA, Kioumourtzoglou MA, Coull B, Suh H. (2017). Erectile dysfunction and exposure to ambient Air pollution in a nationally representative cohort of older Men. Environ Health. 16(1):12.
  125. Zhao S, Wang J, Xie Q, Luo L, Zhu Z, Liu Y, Deng Y, Kang R, Luo J, Zhao Z. (2019). Elucidating Mechanisms of Long-Term Gasoline Vehicle Exhaust Exposure-Induced Erectile Dysfunction in a Rat Model. J Sex Med. 16(2):155-167.
  126. Huisman M, Klok F. (2015). Current challenges in diagnostic imaging of venous thromboembolism. Blood. 126(21):2376–2382.
  127. Wilbur J, Shian B. (2012). Diagnosis of deep venous thrombosis and pulmonary embolism. Am Fam Physician. 86(10):913–919.
  128. Nielsen JD. (2013). The incidence of pulmonary embolism during deep vein thrombosis. Phlebology. 28(suppl 1):29–33.
  129. Makedonov I, Kahn SR, Galanaud JP. (2020). Prevention and Management of the Post-Thrombotic Syndrome. J Clin Med. 9(4):923.
  130. Patel K Deep venous thrombosis (DVT): practice essentials, background, anatomy. emedicine.medscape.com.
  131. Vermylen J. & Hoylaerts M. F. (2007). The procoagulant effects of air pollution. Journal of thrombosis and haemostasis : JTH 5, 250–251.
  132. Peters A., Doring A., Wichmann H. E. & Koenig W. (1997). Increased plasma viscosity during an air pollution episode: a link to mortality? Lancet 349, 1582–1587.
  133. Park S. K. et al. (2008). Traffic-related particles are associated with elevated homocysteine: the VA normative aging study. American journal of respiratory and critical care medicine 178, 283–289.
  134. Rudez G. et al. (2009). Effects of ambient air pollution on hemostasis and inflammation. Environmental health perspectives 117, 995–1001.
  135. Baccarelli A. et al. (2007). Effects of exposure to air pollution on blood coagulation. Journal of thrombosis and haemostasis : JTH 5, 252–260.
  136. Pun VC, Hart JE, Kabrhel C, Camargo CA, Jr, Baccarelli AA, Laden F. (2015). Prospective Study of Ambient Particulate Matter Exposure and Risk of Pulmonary Embolism in the Nurses’ Health Study Cohort. Environ Health Perspect. 123:1265–1270.
  137. Franchini M, Mengoli C, Cruciani M, Bonfanti C, Mannucci PM. (2016). Association between particulate air pollution and venous thromboembolism: A systematic literature review. Eur J Intern Med. 27:10–13.
  138. Tang L, Wang QI, Cheng ZP, Hu B, Liu JD, Hu Y. (2016). Air pollution and venous thrombosis: a meta-analysis. Sci Rep. 6:32794.
  139. Dendup T, Feng X, Clingan S, Astell-Burt T. (2018). Environmental Risk Factors for Developing Type 2 Diabetes Mellitus: A Systematic Review. Int J Environ Res Public Health. 15(1):78.
  140. McGuinn LA, Schneider A, McGarrah RW, Ward-Caviness C, Neas LM, Di Q, Schwartz J, Hauser ER, Kraus WE, Cascio WE, Diaz-Sanchez D, Devlin RB. (2019). Association of long-term PM2.5 exposure with traditional and novel lipid measures related to cardiovascular disease risk. Environ Int. 122:193-200.
  141. Eze IC, Schaffner E, Foraster M, et al. (2015). Long-Term Exposure to Ambient Air Pollution and Metabolic Syndrome in Adults. PLoS One. 10(6):e0130337. Published 2015 Jun 23.
  142. Billings ME, Gold D, Szpiro A, et al. (2019). The Association of Ambient Air Pollution with Sleep Apnea: The Multi-Ethnic Study of Atherosclerosis. Ann Am Thorac Soc. 16(3):363-370.
  143. Miller MR. (2020). Oxidative stress and the cardiovascular effects of air pollution. Free Radic Biol Med. 151:69-87.
  144. Kunzli N., Jerrett M., Mack W.J., Beckerman B., LaBree L., Gilliland F., Thomas D., Peters J., Hodis H.N. (2005). Ambient air pollution and atherosclerosis in Los Angeles. Environ. Health Perspect. 113:201–206.